Device Vascular/Oncology

Ultraverse 014

Payments companies reported to CMS as associated with Ultraverse 014. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$4,035associated payments (2023-2025)
87clinicians with associated payments
2companies reporting

By year

2023 $542
2024 $2,642
2025 $851

Payments reported as associated with Ultraverse 014, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Cardiovascular Disease $1,261
Vascular Surgery $699
Physician Assistant $640
Interventional Cardiology $353
Surgery $116
Nephrology (Internal Medicine) $115

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Ultraverse 014

These are the largest totals companies reported as associated with Ultraverse 014. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Moinakhtar Lala Reseda, CA Cardiovascular Disease $601.36
Mehran Khorsandi Los Angeles, CA Cardiovascular Disease $345.08
Charles Hurd Los Angeles, CA Physician Assistant $251.81
Surrender Raina Stockton, CA Cardiovascular Disease $205.45
Lindsay Okowita Tarzana, CA Physician Assistant $174.80
Ariel Bina Tarzana, CA Physician Assistant $163.67
Ralph Brookshire Edinburg, TX Vascular Surgery $126.62
James Chalk Edinburg, TX Vascular Surgery $126.62
Brian Whyte Beckley, WV Surgery $80.44
Kevin Carrier Los Angeles, CA Medical $69.46

Prescribed Ultraverse 014?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.